Vanda Pharmaceuticals (VNDA) Enterprise Value Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.66% |
| Dec 31, 2025 | 29.57% |
| Sep 30, 2025 | 21.93% |
| Jun 30, 2025 | 16.03% |
| Mar 31, 2025 | 13.51% |
| Dec 31, 2024 | 3.51% |
| Sep 30, 2024 | 23.19% |
| Jun 30, 2024 | 20.78% |
| Mar 31, 2024 | 21.41% |
| Dec 31, 2023 | 16.83% |
| Sep 30, 2023 | -7.71% |
| Jun 30, 2023 | -11.00% |
| Mar 31, 2023 | -15.24% |
| Dec 31, 2022 | -7.87% |
| Sep 30, 2022 | -12.03% |
| Jun 30, 2022 | -11.19% |
| Mar 31, 2022 | -15.08% |
| Dec 31, 2021 | -17.70% |
| Sep 30, 2021 | -16.47% |
| Jun 30, 2021 | -16.67% |
| Mar 31, 2021 | -21.08% |
| Dec 31, 2020 | -17.82% |
| Sep 30, 2020 | -46.58% |
| Jun 30, 2020 | -21.30% |
| Mar 31, 2020 | -16.61% |
| Dec 31, 2019 | -21.28% |
| Sep 30, 2019 | 1.16% |
| Jun 30, 2019 | -21.17% |
| Mar 31, 2019 | -7.64% |
| Dec 31, 2018 | -79.45% |
| Sep 30, 2018 | -71.99% |
| Jun 30, 2018 | -68.63% |
| Mar 31, 2018 | -80.63% |
| Dec 31, 2017 | 28.94% |
| Sep 30, 2017 | 1.89% |
| Jun 30, 2017 | -0.83% |
| Mar 31, 2017 | 0.41% |
| Dec 31, 2016 | -40.96% |
| Sep 30, 2016 | 1.20% |
| Jun 30, 2016 | 7.26% |
| Mar 31, 2016 | -2.98% |
| Dec 31, 2015 | -10.29% |
| Sep 30, 2015 | -157.30% |
| Jun 30, 2015 | -130.62% |
| Mar 31, 2015 | -33.79% |
| Dec 31, 2014 | 0.41% |
| Sep 30, 2014 | 60.55% |
| Jun 30, 2014 | 38.64% |
| Mar 31, 2014 | 9.49% |
| Dec 31, 2013 | -8.26% |
| Sep 30, 2013 | -5.78% |
| Jun 30, 2013 | 28.38% |
| Mar 31, 2013 | 29.46% |
| Dec 31, 2012 | 19.13% |
| Sep 30, 2012 | 16.75% |
| Jun 30, 2012 | 23.19% |
| Mar 31, 2012 | -199.41% |
| Dec 31, 2011 | 24.82% |
| Sep 30, 2011 | -57.56% |
| Jun 30, 2011 | -29.35% |
| Dec 31, 2010 | 3.54% |